This randomized trial assesses whether metformin (vs placebo) given for 5 years would improve invasive disease–free survival and other outcomes in patients with
Genomic test has lower prognostic accuracy in minority patients with breast cancer
Black women have higher recurrence and mortality rates than non-Hispanic white women for certain types of breast cancer, according to a University of Illinois Chicago researcher s study published recently in
JAMA Oncology.
Dr. Kent Hoskins, associate professor in the UIC College of Medicine s division of hematology/oncology, and co-leader of the Breast Cancer Research group in the University of Illinois Cancer Center, published the study, Association of race/ethnicity and the 21-gene Recurrence Score with breast cancer-specific mortality among US women in the Jan. 21 online issue.
Hoskins and the research team sought to discover if breast cancer-specific mortality among women with estrogen receptor-positive, axillary node-negative breast cancer differs by race within risk categories defined by the Oncotype Recurrence Score, or RS, which is a genomic test that analyzes the activity of a group of
E-Mail
Black women have higher recurrence and mortality rates than non-Hispanic white women for certain types of breast cancer, according to a University of Illinois Chicago researcher s study published recently in
JAMA Oncology.
Dr. Kent Hoskins, associate professor in the UIC College of Medicine s division of hematology/oncology, and co-leader of the Breast Cancer Research group in the University of Illinois Cancer Center, published the study, Association of race/ethnicity and the 21-gene Recurrence Score with breast cancer-specific mortality among US women in the Jan. 21 online issue.
Hoskins and the research team sought to discover if breast cancer-specific mortality among women with estrogen receptor-positive, axillary node-negative breast cancer differs by race within risk categories defined by the Oncotype Recurrence Score, or RS, which is a genomic test that analyzes the activity of a group of genes that can affect how a cancer is likely to behave and respond to tre